Biotech · Private company
Helix BioPharma Corporation
Track this companyFree. Adds Helix BioPharma Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- DoxorubicinPhase 2 · Pancreas CancerClinicalTrials.gov · fetched Nov 12, 2026
- L-DOS47Phase 2 · Pancreas CancerClinicalTrials.gov · fetched Nov 12, 2026
- L-DOS47Phase 1 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- L-DOS47 Plus Doxorubicin in Advanced Pancreatic CancerPHASE1_PHASE2 · TERMINATED · started Dec 11, 2019ClinicalTrials.gov NCT04203641 · fetched Nov 12, 2026
- A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLCPHASE1 · TERMINATED · started Apr 20, 2015ClinicalTrials.gov NCT02309892 · fetched Nov 12, 2026